Synergy Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Synergy Investment Management's VRTX Position: Q2 2026 in Review
Synergy Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 381% in Q2 2026, buying an estimated $89.5K and bringing the position to 255 shares worth $124K. The position accounts for 0.03% of the portfolio, ranked #231.
Synergy Investment Management first reported a position in VRTX in Q4 2024 and has held it in 4 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Synergy Investment Management held 255 shares of Vertex Pharmaceuticals worth $124K as of Q2 2026.
- Synergy Investment Management bought 202 Vertex Pharmaceuticals shares in Q2 2026, an estimated $89.5K.
- Vertex Pharmaceuticals made up 0.03% of Synergy Investment Management's portfolio in Q2 2026, its #231 holding.
- Synergy Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Synergy Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.